Praxbind Disease Interactions
There are 2 disease interactions with Praxbind (idarucizumab).
Idarucizumab (applies to Praxbind) fructose intolerance
Moderate Potential Hazard, Moderate plausibility.
The recommended dose of idarucizumab contains 4 g of sorbitol. Caution is advised when prescribing this agent to patients with hereditary fructose intolerance. Consider the combined daily metabolic load of sorbitol/fructose from all sources to avoid serious adverse reactions.
Idarucizumab (applies to Praxbind) liver impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
No formal studies of idarucizumab have been conducted in patients with hepatic impairment. Caution is advised.
Switch to professional interaction data
Praxbind drug interactions
There are 6 drug interactions with Praxbind (idarucizumab).
Report options
More about Praxbind (idarucizumab)
- Praxbind consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anticoagulant reversal agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.